Literature DB >> 19524575

In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.

Ahmad Besaratinia1, Sang-In Kim, Pierre Hainaut, Gerd P Pfeifer.   

Abstract

BACKGROUND & AIMS: Dietary exposure to aflatoxin B(1) (AFB(1)), in addition to other known factors, increases risk for human hepatocellular carcinoma (HCC). HCCs from AFB(1)-exposed individuals frequently have distinct TP53 mutations, such as G to T transversions in the second guanine of codon 249 (AGG to AGT), and a characteristic mutational spectrum predominated by G:C to T:A mutations.
METHODS: To recapitulate the distinctive features of TP53 mutations in AFB(1)-associated HCC, we investigated AFB(1)-induced DNA adduction in relation to mutagenesis in transgenic mouse fibroblasts exposed to AFB(1) in vitro.
RESULTS: Immunodotblot determination of DNA adducts in the overall genome of AFB(1)-exposed cells revealed the dose-dependant formation of persistent imidazole ring-opened AFB(1)-DNA adducts. DNA footprinting analysis of the cII transgene in AFB(1)-exposed cells verified the dose-dependent and sequence-specific formation of DNA adducts. The preferential formation of AFB(1)-induced DNA adducts along the cII transgene was almost exclusively localized to guanine-containing sequences encompassing CpG dinucleotides. Mutation analysis of the cII transgene in AFB(1)-exposed cells revealed a dose-dependent induction of cII mutant frequency (P < .001) and a unique induced mutational spectrum characterized by predominant induction of G:C to T:A transversions that occurred within CpG sequence contexts. Notably, codons 42 and 45 of the cII transgene, which have identical sequence contexts to that of codon 249 of human TP53, constituted 2 frequently mutated sites in AFB(1)-exposed cells that contained the G to T transversion signature mutation at their third base positions.
CONCLUSIONS: In this model system, AFB(1)-induced DNA adduction and mutagenesis recapitulate the unique mutational features of TP53 in AFB(1)-associated human HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524575      PMCID: PMC2736365          DOI: 10.1053/j.gastro.2009.06.002

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  49 in total

1.  Terminal transferase-dependent PCR (TDPCR) for in vivo UV photofootprinting of vertebrate cells.

Authors:  H H Chen; J Kontaraki; C Bonifer; A D Riggs
Journal:  Sci STKE       Date:  2001-04-10

2.  Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis.

Authors:  Y H You; G P Pfeifer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

3.  Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.

Authors:  M F Denissenko; J Cahill; T B Koudriakova; N Gerber; G P Pfeifer
Journal:  Mutat Res       Date:  1999-04-06       Impact factor: 2.433

4.  Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.

Authors:  Adriana M Doi; Paula E Patterson; Evan P Gallagher
Journal:  Toxicol Appl Pharmacol       Date:  2002-05-15       Impact factor: 4.219

Review 5.  The toxicology of aflatoxins as a basis for public health decisions.

Authors:  C P Wild; P C Turner
Journal:  Mutagenesis       Date:  2002-11       Impact factor: 3.000

6.  Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein.

Authors:  Charles R Madden; Milton J Finegold; Betty L Slagle
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  A high pressure liquid chromatography study on the removal of DNA-bound aflatoxin B1 in rat liver and in vitro.

Authors:  P J Hertzog; J R Lindsay Smith; R C Garner
Journal:  Carcinogenesis       Date:  1980-09       Impact factor: 4.944

8.  The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma.

Authors:  Maryann E Smela; Michelle L Hamm; Paul T Henderson; Constance M Harris; Thomas M Harris; John M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

9.  Mispairing of the 8,9-dihydro-8-(N7-guanyl)-9-hydroxy-aflatoxin B1 adduct with deoxyadenosine results in extrusion of the mismatched dA toward the major groove.

Authors:  Indrajit Giri; David S Johnston; Michael P Stone
Journal:  Biochemistry       Date:  2002-04-30       Impact factor: 3.162

Review 10.  The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis.

Authors:  M E Smela; S S Currier; E A Bailey; J M Essigmann
Journal:  Carcinogenesis       Date:  2001-04       Impact factor: 4.944

View more
  29 in total

Review 1.  Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis.

Authors:  Yan Liu; Chung-Chou H Chang; Gary M Marsh; Felicia Wu
Journal:  Eur J Cancer       Date:  2012-03-08       Impact factor: 9.162

Review 2.  Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.

Authors:  Amanda K McCullough; R Stephen Lloyd
Journal:  DNA Repair (Amst)       Date:  2019-03-07

3.  Wavelength dependence of ultraviolet radiation-induced DNA damage as determined by laser irradiation suggests that cyclobutane pyrimidine dimers are the principal DNA lesions produced by terrestrial sunlight.

Authors:  Ahmad Besaratinia; Jae-In Yoon; Christi Schroeder; Stephen E Bradforth; Myles Cockburn; Gerd P Pfeifer
Journal:  FASEB J       Date:  2011-05-25       Impact factor: 5.191

4.  Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct.

Authors:  Ying-Chih Lin; Liang Li; Alena V Makarova; Peter M Burgers; Michael P Stone; R Stephen Lloyd
Journal:  Carcinogenesis       Date:  2014-01-07       Impact factor: 4.944

5.  Mutational Signatures in Breast Cancer: The Problem at the DNA Level.

Authors:  Serena Nik-Zainal; Sandro Morganella
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531

6.  Pathways of Metabolite-Related Damage to a Synthetic p53 Gene Exon 7 Oligonucleotide Using Magnetic Enzyme Bioreactor Beads and LC-MS/MS Sequencing.

Authors:  Spundana Malla; Karteek Kadimisetty; Di Jiang; Dharamainder Choudhary; James F Rusling
Journal:  Biochemistry       Date:  2018-05-23       Impact factor: 3.162

7.  The Lambda Select cII Mutation Detection System.

Authors:  Ahmad Besaratinia; Stella Tommasi
Journal:  J Vis Exp       Date:  2018-04-26       Impact factor: 1.355

8.  Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Jian Huang; Qing Deng; Qun Wang; Kun-Yu Li; Ji-Hong Dai; Niu Li; Zhi-Dong Zhu; Bo Zhou; Xiao-Yan Liu; Rui-Fang Liu; Qian-Lan Fei; Hui Chen; Bing Cai; Boping Zhou; Hua-Sheng Xiao; Lun-Xiu Qin; Ze-Guang Han
Journal:  Nat Genet       Date:  2012-08-26       Impact factor: 38.330

9.  Limited mutagenicity of electronic cigarettes in mouse or human cells in vitro.

Authors:  Stella Tommasi; Steven E Bates; Rachel Z Behar; Prue Talbot; Ahmad Besaratinia
Journal:  Lung Cancer       Date:  2017-08-03       Impact factor: 5.705

10.  Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua.

Authors:  Ying-Chih Lin; Liang Li; Alena V Makarova; Peter M Burgers; Michael P Stone; R Stephen Lloyd
Journal:  J Biol Chem       Date:  2014-05-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.